Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Medicenna Therapeutics Corp (NQ: MDNA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Nov 1, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 0.1510 (5) Ask (Size) 0.1565 (181) Prev. Close 0.1570 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12 October 30, 2023 Intuitive Machines stock is rising on Monday after the company announced plans for a lunar mission launch in January 2024. Via InvestorPlace Why Is Medicenna Therapeutics (MDNA) Stock Down Today? October 30, 2023 Medicenna Therapeutics stock is falling on Monday after the company announced that shares of MDNA will be delisted from the Nasdaq. Via InvestorPlace Performance More News Read More Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket October 30, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 30, 2023 Via InvestorPlace The Latest Analyst Ratings for Medicenna Therapeutics August 14, 2023 Via Benzinga Medicenna Therapeutics's Earnings: A Preview August 08, 2023 Via Benzinga Earnings Preview For Medicenna Therapeutics February 06, 2023 Via Benzinga Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session October 27, 2023 Via Benzinga Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings October 27, 2023 Via Benzinga Topics Stocks Exposures US Equities Medicenna Therapeutics Earnings Preview February 06, 2023 Via Benzinga Medicenna's Lead Cancer Program Shows Preliminary Anti-Cancer Activity In Solid Tumor Study July 27, 2022 Via Benzinga Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket May 22, 2023 Via Benzinga Could CRISPR Therapeutics Help You Become a Millionaire? December 27, 2022 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 November 29, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Monday November 14, 2022 Via Benzinga Earnings Scheduled For November 4, 2022 November 04, 2022 Via Benzinga Earnings Outlook For Medicenna Therapeutics November 03, 2022 Via Benzinga Medicenna Therapeutics: Q1 Earnings Insights August 15, 2022 Via Benzinga Recap: Medicenna Therapeutics Q1 Earnings August 15, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 14, 2022 Via InvestorPlace Stocks That Hit 52-Week Lows On Friday October 28, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 25, 2022 Via Benzinga Earnings Scheduled For August 15, 2022 August 15, 2022 Via Benzinga Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday August 10, 2022 Via Benzinga Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session August 09, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
